Date Filer Filing Type Shares Traded Price Total Held
May 12, 2021
Director, President and CEO
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 295,191
May 12, 2021
Director, President and CEO
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 290,000 -- 585,191
May 12, 2021
Chief Operating Officer
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 240,000 -- 252,086
Apr 23, 2021
Chief Medical Officer
Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 10,000 -- --
Apr 23, 2021
Chief Medical Officer
Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 5,000 -- --
Apr 23, 2021
Chief Medical Officer
Form 3/A Amendment to an Initial Statement of Beneficial Ownership of Securities 10,210 -- --
Apr 01, 2021
Chief Medical Officer
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Apr 01, 2021
Director, President and CEO
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 775,000 -- 775,000
Apr 01, 2021
Chief Operating Officer
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000
Apr 01, 2021
Chief Financial Officer
Form 4 Grant, award or other acquisition pursuant to Rule 16b-3(d) 275,000 -- 275,000

* Represents the number of non-derivative securities directly held. (I) Indicates that some (or all) of these shares are held indirectly.